<- Go Home
Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Market Cap
AUD 376.6M
Volume
853.4K
Cash and Equivalents
AUD 22.4M
EBITDA
AUD 81.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 270.2M
Profit Margin
36.63%
52 Week High
AUD 3.03
52 Week Low
AUD 1.83
Dividend
6.19%
Price / Book Value
2.57
Price / Earnings
14.33
Price / Tangible Book Value
-26.60
Enterprise Value
AUD 669.1M
Enterprise Value / EBITDA
3.29
Operating Income
AUD 68.6M
Return on Equity
16.68%
Return on Assets
7.48
Cash and Short Term Investments
AUD 23.1M
Debt
AUD 315.1M
Equity
AUD 151.0M
Revenue
AUD 737.5M
Unlevered FCF
AUD 177.1M
Sector
Health Care Providers and Services
Category
N/A